Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein

Published:2015-05-11 Issue:7 Volume:35 Page:929-938
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Tanas M R,Ma S,Jadaan F O,Ng C K Y,Weigelt B,Reis-Filho J S,Rubin B P

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2015148.pdf

Reference46 articles.

1. Errani C, Zhang L, Sung YS, Hajdu M, Singer S, Maki RG et al. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer 2011; 50: 644–653.

2. Tanas MR, Sboner A, Oliveira AM, Erickson-Johnson MR, Hespelt J, Hanwright PJ et al. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med 2011; 3: 98ra82.

3. Antonescu CR, Le Loarer F, Mosquera JM, Sboner A, Zhang L, Chen CL et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer 2013; 52: 775–784.

4. Mendlick MR, Nelson M, Pickering D, Johansson SL, Seemayer TA, Neff JR et al. Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma. Am J Surg Pathol 2001; 25: 684–687.

5. Harvey KF, Zhang X, Thomas DM . The Hippo pathway and human cancer. Nat Rev Cancer 2013; 13: 246–257.

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK9 Inhibition by Dinaciclib Is a Therapeutic Vulnerability in Epithelioid Hemangioendothelioma;Clinical Cancer Research;2024-07-25

2. YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer;Annual Review of Cancer Biology;2024-06-12

3. Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges;Pharmacological Research;2024-05

4. Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers;Nature Cancer;2024-04-02

5. Epithelioid hemangioendothelioma—its history, clinical features, molecular biology and current therapy;Japanese Journal of Clinical Oncology;2024-03-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3